… DNA methylation and histone methylation. For instance, the reduced miR-143/miR-145
expression in prostate cancer … biomarkers for prostate cancer diagnosis and drug development. …

… Predictive biomarkers identifying CRPC patients who … DNA methylation is correlated with
cancer progression, our findings show that hypermethylation in the SRD5A2 promoter region, …

… manner, depending on DNA methylation-orchestrated … promoter. We demonstrate that
CTCF deposition at this site as measured by DNA methylation level is highly variable in prostate …

… , but is also reported to be a biomarker of early disease detection. In PC, … prostate tissues.
The expression of PLAU is normally repressed by DNA methylation, but the promoter region of …

… of 147 prostate cancer risk SNPs. The … prostate cancer tissue and the adjacent normal
tissue which has not been done previously; we rigorously dissect the role of DNA methylation in …

… DNA methylation is a stable genomic change which can be investigated noninvasively in …
DNA methylation is a promising CaP DNA biomarker because it is one of the earliest molecular …

… and miRNAs are attractive sources for biomarker discovery … combined miRNA and DNA
methylation multimarker panel … combined miRNA and DNA methylation biomarker panel (miMe) …

… island promoters are methylated in cancer. DNA methylation-based PCa biomarkers are …
to the high prevalence of hypermethylation at specific gene promoters and these have been …

… whether DNA methylation plays a role in the expression of these genes in prostate cancer
cells. … is a potential sensitive and specific prostate cancer biomarker in ctDNA isolated from the …

… of nasopharyngeal carcinoma development. Although many studies detected certain genes
with abnormal DNA hypermethylation or hypomethylation in nasopharyngeal carcinoma, it is …